Exelixis Inc. Common Stock vs Range Nuclear Renaissance ETF — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M). The key difference: Exelixis Inc. Common Stock is far larger — about 20.9× Range Nuclear Renaissance ETF's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Range Nuclear Renaissance ETF for 18 Days on average.
| EXEL | NUKZ | |
|---|---|---|
Market Cap | $14.62B | $698.21M |
Volume | 2,684,957 | 57,444 |
Sector | Health | Sector/Thematic |
52-Week High | $59.13 | $76.23 |
52-Week Low | $34.54 | $60.23 |
Typical Hold Time | 1 Days | 18 Days |
Enterprise Value | $13.95B | — |
Trailing returns across standard periods
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →